Northwest Biotherapeutics, Inc. NWBO
0.17 USD 0.00 (+0.66%)
Nov 10, 2026, 3:54 PM EST
0.1662 Day range 0.1684
0.14 52-week range 0.34
- YTD
- -27.35%
- 1 year
- -33.16%
Revenue & Expenses
Latest period ending Dec 31, 2024 · select a line to chart its full history
Income statement
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 1.38M | 1.93M | 1.68M | 1.00M | 1.29M | |
| 1.38M | 1.93M | 1.68M | 1.00M | 1.29M | |
| -66.51M | -55.51M | -67.18M | -52.70M | -86.61M | |
| -83.78M | -62.60M | -105.03M | 179.13M | -529.82M | |
| -0.07 | -0.06 | -0.10 | -0.06 | -0.73 |
Balance sheet
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 2.17M | 2.13M | 6.96M | 15.17M | 9.98M | |
| 26.73M | 27.86M | 31.32M | 40.16M | 32.90M | |
| 105.71M | 74.92M | 136.37M | 164.15M | 395.85M | |
| 67.44M | 45.56M | 26.25M | 37.94M | 19.86M | |
| -94.49M | -65.77M | -128.10M | -123.99M | -362.95M |
Cash flow
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| -57.02M | -53.64M | -52.77M | -38.30M | -32.09M | |
| -1.01M | -3.44M | -2.90M | -6.01M | -8.14M | |
| 56.78M | 52.76M | 41.97M | 48.13M | 52.70M | |
| -1.01M | -3.44M | -2.90M | -6.01M | -6.61M | |
| 49.00K | -4.84M | -8.20M | 5.19M | 9.61M |